Elbit Imaging Ltd. (EMITF)
Stock Price:
$1.25 USD
0.04 (3.31%)
Updated Jul 31, 2020 4:00 PM EDT - End of day
Key Info
| Market Cap |
11.49M |
| Revenue (ttm) |
22.65M |
| Net Income (ttm) |
-137.72M |
| Shares Out |
9.19M |
| EPS (ttm) |
-8.32 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 31, 2020 |
| Last Price |
$1.25 |
| Previous Close |
$1.21 |
| Change ($) |
0.04 |
| Change (%) |
3.31% |
| Day's Open |
1.17 |
| Day's Range |
1.01 - 1.25 |
| Day's Volume |
4,952 |
| 52-Week Range |
0.32 - 1.64 |
More Stats
| Market Cap |
11.49M |
| Enterprise Value |
79.18M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
9.19M |
| Float |
4.91M |
| EPS (basic) |
n/a |
| EPS (diluted) |
-8.32 |
| FCF / Share |
-0.34 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
3,847 |
| Short Ratio |
0.48 |
| Short % of Float |
0.06% |
| Beta |
0.70 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
0.51 |
| PB Ratio |
n/a |
| Revenue |
22.65M |
| Operating Income |
19.48M |
| Net Income |
-137.72M |
| Free Cash Flow |
-3.09M |
| Net Cash |
-67.69M |
| Net Cash / Share |
-7.36 |
| Gross Margin |
100.00% |
| Operating Margin |
85.98% |
| Profit Margin |
-607.90% |
| FCF Margin |
-13.63% |
| ROA |
-10.22% |
| ROE |
n/a |
| ROIC |
-85.40% |
Key stats in USD, based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions ILS.
Financial Overview
| Year | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 85.18 | - | - | 1.47 | 22.57 | 1.97 | 30.38 | 2.27 | 880 |
| Revenue Growth | - | - | - | -93.48% | 1048.8% | -93.53% | 1239.46% | -99.74% | - |
| Gross Profit | 85.18 | - | - | 1.47 | 10.25 | 1.97 | 30.38 | 2.27 | 185 |
| Operating Income | 73.24 | -14.72 | -10.00 | -10.40 | -16.86 | -57.00 | -20.37 | -58.48 | 35.75 |
| Net Income | -518 | -338 | -195 | -186 | -17.05 | -1,156 | -316 | -265 | 62.00 |
| Shares Outstanding | 9.19 | 9.19 | 9.16 | 8.30 | 0.41 | 0.41 | 0.41 | - | - |
| Earnings Per Share | -56.34 | -36.78 | -21.20 | - | - | - | -708.00 | -639.00 | 127.80 |
| Operating Cash Flow | -20.29 | 434 | 77.03 | -86.22 | -11.58 | 14.89 | -3.57 | 21.16 | -333 |
| Capital Expenditures | 8.68 | -0.46 | 19.41 | -0.10 | -0.44 | -0.98 | -1.75 | -6.74 | -41.64 |
| Free Cash Flow | -11.61 | 433 | 96.44 | -86.32 | -12.02 | 13.91 | -5.32 | 14.42 | -375 |
| Cash & Equivalents | 42.11 | 476 | 37.49 | 51.76 | 95.86 | 132 | 75.25 | 1,012 | 0.00 |
| Total Debt | 297 | 1,024 | - | - | 756 | 194 | 1,904 | 6,407 | - |
| Net Cash / Debt | -255 | -548 | 37.49 | 51.76 | -660 | -62.19 | -1,828 | -5,395 | 0.00 |
| Assets | 256 | 1,017 | 50.05 | 67.95 | 1,044 | 1,832 | 3,034 | 10,371 | - |
| Liabilities | 316 | 1,166 | 18.64 | 14.69 | 812 | 209 | 2,745 | 8,832 | - |
| Book Value | -39.70 | -194 | 31.41 | 53.26 | 232 | 59.67 | 289 | 360 | - |
Numbers in millions ILS, except per-share numbers.
Company Details
| Full Name |
Elbit Imaging Ltd. |
| Country |
Israel |
| Employees |
5 |
| CEO |
Ron Hadassi |
Stock Information
| Ticker Symbol |
EMITF |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
OTCMKTS: EMITF |
| IPO Date |
November 27, 1996 |
Description
Elbit Imaging Ltd., together with its subsidiaries, engages in research and development, production, and marketing of treatment-oriented medical systems; and products to treat cancer diseases. Its treatment-oriented medical systems include magnetic resonance imaging for the purpose of performing noninvasive treatments in human beings. The company is also involved in the sale of plots in India. It has operations in the United States, Europe, and internationally. The company was founded in 1996 and is headquartered in Petach Tikva, Israel.